Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
27m agoSunrun Prices $584 million Securitization of Residential Solar and Storage Assets
27m agoMadison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
51m agoUltra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
51m agoGridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
51m agoRush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

Allergy Therapeutics

About

Allergy Therapeutics (LSE:AGY) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 31 2026
Interim Results for six months ended 31 Dec 2025
Mar 12 2026
PDMR Dealings & Shareholding Update
Mar 4 2026
Positive Biomarker Results from PROTECT Trial
Feb 26 2026
Allergy Therapeutics presents progress at AAAAI
Feb 23 2026
Update on funding and total voting rights

Financials

Revenue
GBX57.29 M
Market Cap
GBX652.25 M
EPS
-0.01

Community Chat

Ask AI

6ix6ixAIEvents